It has been demonstrated that MEOX2 expression level is correlated with its methylation status in glioma samples and that downregulation of MEOX2 leads to increased viability in glioma stem cells through modulation of the ERK/MAPK pathway.38 The gene discussed is MEOX2; the disease is central nervous system cancer.